Bronchial Artery Chemoembolization (BACE) Combined with PD-1 Blockade Versus Chemotherapy Combined with PD-1 Blockade for Non-Small Cell Lung Cancer in Older Adults. [PDF]
Xiang J +8 more
europepmc +1 more source
Double spring coil transarterial chemoembolization approach integrating with sorafenib for hepatocellular carcinoma patients with portal vein tumor thrombus: A retrospective cohort study. [PDF]
Ning S +9 more
europepmc +1 more source
Balloon-Occluded Transarterial Chemoembolization for Hepatocellular Carcinoma: Technical Rationale, Current Evidence, and Future Directions. [PDF]
Jia X +5 more
europepmc +1 more source
Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients. [PDF]
Arendt N +5 more
europepmc +1 more source
Transarterial chemoembolization (TACE) with or without immune checkpoint inhibitors in unresectable hepatocellular carcinoma: a meta-analysis of randomized clinical trials. [PDF]
Kim H +4 more
europepmc +1 more source
Invariant Natural Killer T Cell Therapy Attenuates Systemic Inflammation and Improves Transarterial Chemoembolization Outcomes in Hepatocellular Carcinoma. [PDF]
Wang X +6 more
europepmc +1 more source
DEB-TACE-HAIC combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma: a multicenter retrospective study. [PDF]
Ma Y +8 more
europepmc +1 more source
Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety. [PDF]
Quan Y +12 more
europepmc +1 more source
Qian Zhou, Xiao-Qing Zhou, Tao Zhang
openaire +1 more source
Transarterial Radioembolization Versus Transarterial Chemoembolization in Elderly Patients (≥75 Years) With Hepatocellular Carcinoma: A Propensity Score-Matched Comparison. [PDF]
Cho CY +6 more
europepmc +1 more source

